Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
AIMS: Inappropriate sinus tachycardia (IST) is a clinical syndrome characterized by excessive resting heart rate (HR) or disproportional increasing HR during exercise. The treatment of IST symptoms using beta-blockers or calcium channel-blockers is often non-effective or not well tolerated. Ivabradine is a new agent inhibiting sinus node I(f) current, resulting in a decrease of HR without haemodynamic compromise. METHODS AND RESULTS: We enrolled 20 patients (36 ± 10 years; 14 women) affected by IST and resistant to previous administered therapy by using beta-blockers or verapamil. After 4 weeks of treatment with metoprolol succinate (up to 190 mg once a day) the therapy was switched to ivabradine up to 7.5 mg twice daily. Holter monitoring and treadmill stress test were performed after 1 and 2 months following start of the study. We observed a significant reduction of resting HR both for metoprolol and for ivabradine compared with baseline (92.8 vs. 90.2 vs. 114.3 b.p.m.; P< 0.001). During daily activity there was an even larger decrease of HR on ivabradine (mean daytime HR 94.6 vs. 87.1 vs. 107.3 b.p.m.; P< 0.001). Ivabradine was very well tolerated whereas in 10 patients on metoprolol we observed hypotension or bradycardia requiring dose reduction. Significantly lower incidence of IST-related symptoms were registered on ivabradine therapy than on metoprolol. Fourteen patients (70%) treated with I(f) blocker were free of IST-related complaints. CONCLUSIONS: Metoprolol and ivabradine exert a similar effect on resting HR in patients with IST. Ivabradine seems to be more effective to relieve symptoms during exercise or daily activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, exercise training has also proven effective for physical reconditioning and lessening episodes of sinus tachycardia triggered by hemodynamic, postural, and/or physical stressors in patients with autonomic nervous system conditions and no underlying familial or personal history of heart disease49,185,192,195,196.”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [196]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Emerging data comparing head-to-head ivabradine vs. metoprolol indicates that patients with IST derive more benefit from ivabradine. 71”
From Inappropriate sinus tachycardia (2019) · cites this paper as [71]
In the citing paper
“ivabradine, a selective If current blocker that directly slows the HR without influence on intraventricular conduction, contractility, or haemodynamics, has been found safe and effective in multiple small trials (Table 9).85,86”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [86]
In the citing paper
“In a more recent study of 20 patients, ivabradine had a similar effect on resting heart rate as metoprolol but was more effective in relieving symptoms during exercise or daily activity, and was better tolerated.86”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099
Tardif, J.-C., Ford, I., Tendera, M., Bourassa, M. G., & Fox, K. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi586 · Cited by 582
Tardif, J.-C., Ponikowski, P., Kahan, T., & for the ASSOCIATE study Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn571 · Cited by 340
Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., et al. (2007) · Europace · doi:10.1093/europace/eum191 · Cited by 293
Radiofrequency catheter modification of the sinus node for “inappropriate” sinus tachycardia
Lee, R. J., Kalman, J. M., Fitzpatrick, A. P., Epstein, L. M., Fisher, W. G., Olgin, J. E., Lesh, M. D., & Scheinman, M. M. (1995) · Circulation · doi:10.1161/01.cir.92.10.2919 · Cited by 213
Mechanism of ”inappropriate” sinus tachycardia. Role of sympathovagal balance
Morillo, C. A., Klein, G. J., Thakur, R. K., Li, H., Zardini, M., & Yee, R. (1994) · Circulation · doi:10.1161/01.cir.90.2.873 · Cited by 193
Inappropriate sinus tachycardia
Olshansky, B., & Sullivan, R. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.074 · Cited by 182
Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping
Man, K. C., Knight, B., Tse, H.-F., Pelosi, F., Michaud, G. F., Flemming, M., Strickberger, S. A., & Morady, F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00546-x · Cited by 142
Research works printed but not linked: 3
- 2. Cossu SF, Steinberg JS. Supraventricular tachyarrhythmias involving the sinus node: clinical and electrophysiologic characteristics. Prog Cardiovasc Dis 1998; 41 : 51-63.
- 2009, Wiener klinische Wochenschrift, 121, 716
- 28. Joannides R, Moore N, Iacob M, Compagnon P, Lerebours G, Menard JF et al. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol 2006; 61 :127-37.
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström-Lundqvist, C., Calkins, H., Corrado, D., Deftereos, S. G., Diller, G.-P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,230
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes III, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.019 · Cited by 206
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188
The Clinical Use of Ivabradine
Koruth, J. S., Lala, A., Pinney, S., Reddy, V. Y., & Dukkipati, S. R. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.038 · Cited by 176
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000310 · Cited by 175
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H. G., CONTI, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.019 · Cited by 111
Inappropriate sinus tachycardia
Olshansky, B., & Sullivan, R. M. (2019) · EP Europace · doi:10.1093/europace/euy128 · Cited by 80
Sinus Tachycardia: a Multidisciplinary Expert Focused Review
Mayuga, K. A., Fedorowski, A., Ricci, F., Gopinathannair, R., Dukes, J. W., Gibbons, C., Hanna, P., Sorajja, D., Chung, M., Benditt, D., et al. (2022) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.121.007960 · Cited by 59
Ptaszynski, P., Kaczmarek, K., Ruta, J., Klingenheben, T., Cygankiewicz, I., & Wranicz, J. K. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413478172 · Cited by 57
Self-citationBENEZET‐MAZUECOS, J., RUBIO, J. M., FARRÉ, J., QUIÑONES, M. Á., SANCHEZ‐BORQUE, P., & MACÍA, E. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12118 · Cited by 55
Becker, R. C. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02549-6 · Cited by 64
Ablation of Inappropriate Sinus Tachycardia
Rodríguez-Mañero, M., Kreidieh, B., Al Rifai, M., Ibarra-Cortez, S., Schurmann, P., Álvarez, P. A., Fernández-López, X. A., García-Seara, J., Martínez-Sande, L., González-Juanatey, J. R., et al. (2017) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2016.09.014 · Cited by 47
Inappropriate Sinus Tachycardia: Etiology, Pathophysiology, and Management
Ahmed, A., Pothineni, N. V. K., Charate, R. A., Garg, J., Elbey, M. A., de Asmundis, C., Meir, M. L., Romeya, A., Shivamurthy, P., Olshansky, B., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.019 · Cited by 60
JACOBSON, J. T., KRAUS, A., LEE, R., & GOLDBERGER, J. J. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12318 · Cited by 42
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 65
Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
Wołowiec, Ł., Grześk, G., Osiak, J., Wijata, A., Mędlewska, M., Gaborek, P., Banach, J., Wołowiec, A., & Głowacka, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043714 · Cited by 58
Ivabradine: A Review of Labeled and Off-Label Uses
Oliphant, C. S., Owens, R. E., Bolorunduro, O. B., & Jha, S. K. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0178-z · Cited by 38
Ivabradine in Cardiovascular Disease Management Revisited: a Review
Chen, C., Kaur, G., Mehta, P. K., Morrone, D., Godoy, L. C., Bangalore, S., & Sidhu, M. S. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07124-4 · Cited by 35
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H. G., CONTI, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.018 · Cited by 40
Mathew, S. T., Po, S. S., & Thadani, U. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.004 · Cited by 29
Treatment of inappropriate sinus tachycardia with ivabradine
Martino, A., Lupo, P. P., Foresti, S., Ambroggi, G. D., Ruvo, E. D., Sciarra, L., Cappato, R., & Calò, L. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0066-5 · Cited by 28
Challenges in Treatment of Inappropriate Sinus Tachycardia
Ruzieh, M., Moustafa, A., Sabbagh, E., Karim, M. M., & Karim, S. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x13666171129183826 · Cited by 33
Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series
Lally, J., Brook, J., Dixon, T., Gaughran, F., Shergill, S. S., Melikian, N., & MacCabe, J. H. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125313512325 · Cited by 28
Inappropriate sinus tachycardia: focus on ivabradine
Abed, H. S., Fulcher, J., Kilborn, M. J., & KEECH, A. C. (2016) · Internal Medicine Journal · doi:10.1111/imj.13093 · Cited by 28
Major publications in the critical care pharmacotherapy literature in 2015
Wong, A., Erdman, M. J., Hammond, D. A., Holt, T., Holzhausen, J. M., Horng, M., Huang, L. L., Jarvis, J., Kram, B., Kram, S. J., et al. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160144 · Cited by 24
2020 Clinical practice guidelines for Supraventricular tachycardia in adults
Bokeria, L. A., Golukhova, E. Z., Popov, S. V., Artyukhina, Е. А., Базаев, В. А., Batalov, R. E., Bokeria, O. L., Vygovsky, A. B., Gilyarov, M. Y., Sp, G., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4484 · Cited by 24
de Asmundis, C., Chierchia, G.-B., Sieira, J., Ströker, E., Umbrain, V., Poelaert, J., Brugada, P., & La Meir, M. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.04.019 · Cited by 22
Inappropriate sinus tachycardia in pregnancy: a benign phenomena?
Belham, M., Patient, C. J., & Pickett, J. A. (2017) · BMJ Case Reports · doi:10.1136/bcr-2016-217026 · Cited by 23
de Asmundis, C., Chierchia, G., Lakkireddy, D., Romeya, A., Okum, E. J., Gandhi, G. D., Sieira, J. A., Vloka, M. E., Jones, S. D., Shah, H., et al. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-01044-5 · Cited by 26
de Asmundis, C., Pannone, L., Lakkireddy, D., Beaver, T. M., Brodt, C. R., Lee, R. J., Sorgente, A., Gauthey, A., Monaco, C., Overeinder, I., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.07.041 · Cited by 20
Inappropriate sinus tachycardia: a review
Ali, M., Haji, A. Q., Kichloo, A., Grubb, B. P., & Kanjwal, K. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204139 · Cited by 25
Ptaszynski, P. A., Kaczmarek, K. A., Klingenheben, T., Cygankiewicz, I., Ruta, J., & Wranicz, J. K. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.04.057 · Cited by 16
Self-citationRole of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review
Petite, S. E., Bishop, B. M., & Mauro, V. F. (2016) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000388 · Cited by 17
Tolani, D., Misier, N. L. R., Alqahtani, M., Tindel, K., de Groot, N. M. S., Scott, W. A., & Nguyen, H. H. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.10.013 · Cited by 15
de Asmundis, C., Pannone, L., Lakkireddy, D., Beaver, T. M., Brodt, C. R., Lee, R. J., Frazier, K., Chierchia, G., & Meir, M. L. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.01.005 · Cited by 18
Inappropriate Sinus Tachycardia: Current Challenges and Future Directions
Yasin, O. Z., Vaidya, V. R., CHACKO, S., & Asirvatham, S. J. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090706 · Cited by 17
2025 Clinical practice guidelines for Supraventricular tachycardias
Popov, S. V., Davtyan, K. V., Shubik, Y. V., Artyukhina, Е. А., Базаев, В. А., Batalov, R. E., Bokeria, L. A., Bubnova, M. G., Vygovsky, A. B., Sp, G., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6448 · Cited by 14
Is There a Role for Ivabradine Beyond its Conventional Use?
Bonadei, I., Vizzardi, E., Sciatti, E., Carubelli, V., Lombardi, C., D’Aloia, A., & Metra, M. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12080 · Cited by 11
Shabtaie, S. A., Witt, C. M., & Asirvatham, S. J. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14942 · Cited by 11
Martino, A., Rebecchi, M., Sette, A., Cicogna, F., Politano, A., Sgueglia, M., de Ruvo, E., Volterrani, M., & Calo’, L. (2021) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001203 · Cited by 9
Gomes, J. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45066-3_22 · Cited by 9
Li, T., Marashly, Q., Kim, J. A., Li, N., & Chelu, M. G. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2351501 · Cited by 10
Kaczmarek, K. A., Klingenheben, T., Poddębska, I., Urbanek, I., Wranicz, J. K., Cygankiewicz, I., & Ptaszynski, P. A. (2019) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12709 · Cited by 9
Self-citationKatritsis, D. G., Boriani, G., Cosío, F. G., Jaïs, P., Hindricks, G., Josephson, M. E., Keegan, R., Knight, B. P., Kück, K., Lane, D. A., et al. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:5.3.gl1 · Cited by 8
Pregnancy-related inappropriate sinus tachycardia: A cohort analysis of maternal and fetal outcomes
Sharp, A. J., Patient, C. J., Pickett, J. A., & Belham, M. (2021) · Obstetric Medicine · doi:10.1177/1753495x21990196 · Cited by 9
The Use and Indication of Ivabradine in Heart Failure
Dodd, K. S., & Lampert, B. C. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.06.001 · Cited by 7
‘Inappropriate’ Sinus Tachycardia: Does the 100 Beats Per Min cut-off matter?
Hottigoudar, R. U., & Gopinathannair, R. (2013) · Future Cardiology · doi:10.2217/fca.13.5 · Cited by 6
Hellenbart, E. L., Griffin, T., & DiDomenico, R. J. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2391 · Cited by 7
Cardiac Arrhythmias and Pregnancy
SPEARS, D. A., & Elkayam, U. (2019) · Wiley eBooks · doi:10.1002/9781119409861.ch15 · Cited by 6
Conventional management of inappropriate sinus tachycardia
Olshansky, B., & Sullivan, R. M. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0034-0 · Cited by 7
Ivabradine for inappropriate sinus tachycardia: another piece of evidence
Wichterle, D. (2012) · EP Europace · doi:10.1093/europace/eus263 · Cited by 5
Treatment for Inappropriate Sinus Tachycardia
Adum, J. P. S., & Arora, R. R. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000335 · Cited by 4
Bunin, Y. А., Miklishanskaya, S. V., Александровна, З. Е., & Васильевна, Ч. В. (2019) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2019-15-1-115-124 · Cited by 5
de Asmundis, C., Marcon, L., Pannone, L., Rocca, D. G. D., Lakkireddy, D., Beaver, T. M., Brodt, C. R., Monaco, C., Sorgente, A., Audiat, C., et al. (2023) · EP Europace · doi:10.1093/europace/euad373 · Cited by 5
Off-Label Medicines Use: Complex Problem of Modern Clinical Practice
Gilyarevskiy, S. R. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-04-14 · Cited by 5
Schleifer, J. W., Jaroszewski, D. E., Shah, N., & Scott, L. R. (2015) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2015.08.001 · Cited by 3
“A randomized crossover trial of 20 patients demonstrated persistent IST symptoms in 30% of patients on ivabradine compared with 55% of patients on metoprolol.(4) Symptoms also frequently recur after endocardial sinus node modification.”
BackgroundMethodEltsov, I., Pannone, L., Rocca, D. G. D., Lakkireddy, D., Beaver, T. M., Brodt, C. R., Talevi, G., Sorgente, A., Overeinder, I., Kronenberger, R., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.1966 · Cited by 3
Rajendram, R., AlDhahri, F., Mahmood, N., & Kharal, M. (2020) · BMJ Case Reports · doi:10.1136/bcr-2019-230647 · Cited by 3
Tamargo, J. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-34893-9_6 · Cited by 3
Treatment of inappropriate sinus tachycardia: Still a long way to go
Cappato, R. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14940 · Cited by 3
Горелов, А. В., Плоскирева, А. А., Ruzhentsova, T. A., Семененко, Т. А., Oynotkinova, O. S., Voevoda, M. I., Небиеридзе, Д. В., & Кукушкин, С. К. (2020) · Academy of medicine and sports · doi:10.15829/2712-7567-2020-1-45-85 · Cited by 3
Anti-arrhythmic Drugs—a Review and Comment on Relevance in the Current Era: Part 1
Hanayneh, S., Panna, M. E., Miles, W. M., & Goel, R. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00940-3 · Cited by 2
Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
Podzolkov, V. I., Bragina, A. E., Tarzimanova, A. I., Vargina, T. S., Сергеевна, О. Е., Игоревич, Ш. И., Bykova, E. E., & Ivannikov, A. A. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3485 · Cited by 2
De, M., Ghosh, A., Das, U. S., Ghosh, S., & Paul, S. (2019) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2019/647 · Cited by 3
Exploring Resting Sinus Tachycardia in Cancer Care: A Comprehensive Review
Fakih, Y., Sakan, M. M. A., Ghazawi, A. E., Khoury, M., & Refaat, M. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030985 · Cited by 2
Should Ivabradine be First‐Line Therapy for Inappropriate Sinus Tachycardia?
Khan, A. H., Ling, J., Parikh, V. K., & Bekheit, S. (2025) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.15214 · Cited by 1
Ivabradine: Evolving role as an antiarrhythmic agent
Janson, C. M. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.06.039 · Cited by 2
Pannone, L., Duong, N. C., Eltsov, I., Laviola, D., Doundoulakis, I., Rocca, D. G. D., Călburean, P., Pašara, V., Carmagnola, L., Sattin, T., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.02.054 · Cited by 1
Tratamiento de las taquicardias
Arantzamendi, L. G., Elizondo-Rua, I., Torres, M. F. A., & Merodio, J. M. O. (2013) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(13)70620-6 · Cited by 2
The Choice Of Optimal Coronary Stents: Is It Possible To Maximize Cost-Effectiveness?
Gupta, R. (2016) · Journal of Clinical Trials in Cardiology · doi:10.15226/2374-6882/3/1/00138 · Cited by 1
Is heart rate in post-hematopoietic stem cell transplant patients clinically relevant?
López‐Candales, A., Mathur, P., Mounsey, J. P., & Veeraputhiran, M. K. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1995263 · Cited by 1
Urbanek, I., Kaczmarek, K. A., Wranicz, J. K., & Ptaszynski, P. A. (2024) · In a good rythm · doi:10.5604/01.3001.0054.7945 · Cited by 1
Self-citationTaduri, A., Kotha, R., & Singh, T. H. (2019) · Indian Journal of Child Health · doi:10.32677/ijch.2019.v06.i10.015 · Cited by 1
Daher, G. E., Rachwan, R. J., Hassanieh, I., Malhotra, N., Bteich, F., Diab, K. A., & MEHDIRAD, A. A. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00846-3 · Cited by 1
Modern treatment of supraventricular tachycardia
Tarzimanova, A. I., & Podzolkov, V. I. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2020-2694 · Cited by 1
Inadekvát, aránytalan sinuscsomó-tachycardia: egy régi szívritmuszavar új megvilágításban (II.)
Borbola, J., Földesi, C., Kardos, A., & Som, Z. (2020) · Orvosi Hetilap · doi:10.1556/650.2020.31887 · Cited by 1
Monaco, C., Sorgente, A., Ramak, R., Chierchia, G., Meir, M. L., & de Asmundis, C. (2021) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-021-00778-z · Cited by 1
Arrhythmias in Women: A Practical Approach
Lee, R., & TOMPKINS, C. M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5517-1_10
Inappropriate sinus tachycardia – clinical picture and possible psychogenic basis
Rasmus, P., Kozłowska, E., Ruchała, J., Ptaszynski, P. A., Kaczmarek, K. A., & Sobów, T. (2014) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2014.0034
Self-citationEin Herz ohne Drehzahlbegrenzung
Gähwiler, R., Templin, C., Lüscher, T. F., & Ghadri, J. R. (2014) · Praxis · doi:10.1024/1661-8157/a001644
Management of inappropriate sinus tachycardia
Meredith, T., Griffiths, A., & Wong, K. C. K. (2013) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2013.8.12.588 · Cited by 1
Inappropriate sinus tachycardia — ailment or disease?
Ptaszynski, P. A., Kaczmarek, K. A., Poddębska, I., & Cygankiewicz, I. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0267 · Cited by 2
Self-citationTrudności związane z rozpoznawaniem i leczeniem nieadekwatnej tachykardii zatokowej
Daniłowicz‐Szymanowicz, L., & Raczak, G. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0268
Managing the patient with episodic sinus tachycardia and orthostatic intolerance
Narichania, A. D., Schleifer, J. W., & Shen, W.-K. (2014) · Cardiology Journal · doi:10.5603/cj.2014.0098
Kaczmarek, K. A., & Cygankiewicz, I. (2013)
Self-citationNew Antiarrhythmic Drugs and New Concepts for Old Drugs
Kirchhof, P. F. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00112-6
Demarie, D. (2015) · Journal of Clinical Trials in Cardiology · doi:10.15226/2374-6882/2/4/00131 · Cited by 1
OBSOLETE: Sinus Tachycardias: Inappropriate Sinus Tachycardia and Postural Tachycardia Syndrome
Raj, S. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99799-x
Innovations in Antiarrhythmic Drug Therapy
Kirchhof, P. F., & Fabritz, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00113-9
Choudhury, M. (2016) · Journal of Clinical Trials in Cardiology · doi:10.15226/2374-6882/3/1/00135
[Vaccination schedule for children].
Stickl, H. (1980) · PubMed
Kalatsei, L. V., & Snezhitskiy, V. А. (2020) · Journal of the Grodno State Medical University · doi:10.25298/2221-8785-2020-18-2-193-202
Egy új ritmuszavar-entitás: szubaránytalan sinuscsomó-tachycardia
Borbola, J., Földesi, C., Kardos, A., & Som, Z. (2021) · Cardiologia Hungarica · doi:10.26430/chungarica.2021.51.1.49
COVID-19 utáni nem adekvát sinustachycardia, terhelési intolerancia kezelése ivabradinnal
Tomcsányi, J. (2021) · Cardiologia Hungarica · doi:10.26430/chungarica.2021.51.2.140
Antiarrhythmic Agents: a Review and Comment on Relevance in the Current Era—Part 2
Hanayneh, S., Panna, M. E., Miles, W. M., & Goel, R. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00944-z · Cited by 1
Kang, G.-H. (2016) · International Journal of Arrhythmia · doi:10.18501/arrhythmia.2016.034
Sinus Tachycardias: Inappropriate Sinus Tachycardia and Postural Tachycardia Syndrome
Shaw, B. H., Ng, J., & Raj, S. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99799-0
Metadata
- Authors
- Ptaszynski, P., Kaczmarek, K., Ruta, J., Klingenheben, T., & Wranicz, J. K.
- Affiliations
- Medical University of Lodz (PL)
- Corresponding author
- Ptaszynski, P.
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-07-06
- Volume
- 15
- Issue
- 1
- Pages
- 116-121
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W1975581659
- Cited by
- 106
- References
- 34
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 16 · 2020: 10 · 2019: 8 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 11 · 2014: 4 · 2013: 13 · 2012: 1
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- EP Europace (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- inappropriate sinus tachycardia, metoprolol succinate, ivabradine, resting heart rate, exercise-induced tachycardia, beta-blockers, verapamil, drug tolerability, hypotension, bradycardia
- MeSH terms
- Ivabradine, Adrenergic beta-Antagonists, Adult, Anti-Arrhythmia Agents, Benzazepines, Female, Humans, Male, Metoprolol, Tachycardia, Sinus, Treatment Outcome, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.